Why did you participate in the Biomapas Academy?
Everything started when I had a trip to a career fair during my studies. This was the first time I met Biomapas in person as there were several lecturers that presented the company itself and its activities. I remember thinking that I would like to work with this team as it piqued my interest.
Later, when I was working on my master’s degree, I came across an advertisement on social media for the Biomapas Academy. I already knew that I wanted to learn more about the pharma industry and was interested in various opportunities, so I applied for this opportunity.
How was your experience during the three months?
The Academy was a continuous cycle spanning several months of interesting lectures from true professionals with extensive knowledge. During this short time, I learned a lot about product development, research, safety information and its systems, different possible roles and their responsibilities, and new opportunities where young specialists can grow and find their place in the life sciences industry.
What did the future hold for you after the Academy?
A while after the Academy, I officially became part of Biomapas and its big family! With my background being an MPharm, I was always interested in drug safety. Therefore, I am working in the Pharmacovigilance Department as a Pharmacovigilance Project Management Assistant. I must say there are many interesting things to learn and experience that I am looking forward to with my team.
What would you say to the future participants?
If you are thinking about participating in the Academy, do not hesitate. Being an alumnus, I can say that you will definitely see the pharma industry from within. It will broaden your understanding; you will gain needed knowledge and experience in life sciences and will be able to apply that information working in your chosen field. I hope to see you at Biomapas!
Biomapas Academy
What is Clinical Research? Regulatory Affairs? Pharmacovigilance?
CSV & Risk Management in Pharmacovigilance
CSV & Risk Management Pharmacovigilance stands as a guardian in drug development and monitoring, ensuring that medicines remain safe and effective throughout their lifecycle. But behind this sentinel lies a complex web of systems, processes, and regulations, each...
Clinical Endpoints In Early Phase Oncology Trials
Clinical Endpoints In Early Phase Oncology Trials: Discover their influence on safety, study design, and regulatory compliance.
Discover how ICSR Pharmacovigilance safeguards drug safety for patients.
How individual case study reporting tracks adverse drug reactions and helps ensuring medication safety.
Case Study CSV
Learn how to go about Computerized Systems Validation for a cloud-based Safety Database in this Biomapas Case Study.
Choosing A Global Or Local CRO: A Comparative Analysis
Choosing a global or local cro? Learn what to consider when selecting a partner for global trials that require specialized, local expertise.
Rescue Study Strategies for Clinical Trials
How can a rescue study swiftly put your trial back on track? Learn all about rescue strategies and working with a rescue study CRO.
Expert Guidance on PSURs: Ensuring Drug Safety
Why are PSURs important? How do you write a PSUR? Find out all how PSURs and their role in guaranteeing patient safety.
Setting Up a Phase 1 Oncology Study
Explore setting up a Phase 1 Oncology Study successsfully! Learn about critical preparation, meticulous planning, and effective execution.
Safety Monitoring in Early Phase Oncology Trials: Key Points to Consider
For all clinical trials, it is crucial that the potential benefits of a medicinal product are determined, while monitoring any potential side effects. However, for early-phase oncology trials, the extensive monitoring of adverse events (AEs) is essential, considering...
Literature Monitoring in Pharmacovigilance
Incorporating data from medical and scientific literature is a paramount aspect of patient safety. This wealth of knowledge often constitutes a substantial part of the safety profile of medicinal products. From providing insights on potential side effects to shedding...
